Weight Loss
Resource Center
/ Most Recent /
The Bone-Loss Problem in the GLP-1 Era
In the GLP-1 era, practitioners are helping patients lose weight faster and in larger amounts than before. That makes skeletal protection increasingly important. This article examines five signals that change during weight loss—mechanical loading, estrogen, calcium balance, gut delivery, and rate—and translates them into practical considerations for screening and intervention.
GLP-1 Weight-Loss Drugs and Optic Nerve Risks: What Clinicians and Patients Should Know
The rapid global adoption of glucagon-like peptide-1 (GLP-1) receptor agonists-such as semaglutide (Ozempic®, Wegovy®) and related agents-has reshaped the pharmaceutical management of diabetes and obesity. As
GLP-1 Agonists: Support Protocol
A comprehensive plan for patients taking GLP-1s is crucial—no matter how you feel about it. When GLP-1 agonists first hit the market, frustrated Americans
Study Finds Link Between Obesity and Key Nutrient Deficiency
Incidence of adult obesity has doubled in the past 25 years, with almost 1 billion people worldwide—about 1 in every 8—classified as obese in 2022.
Stopping GLP-1 Receptor Agonists… Why and How to Plan an “Exit Strategy” for Your Patients
In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes
Acknowledging Gender Differences in Obesity Research
With the celebration of International Women’s Day on March 8th, it’s timely to review the differences in women’s health research and how that specifically affects
Researchers Link Abdominal Fat to Brain Health in Men
According to the World Health Organization, some 55 million people globally suffer from Alzheimer’s disease or dementia. With 10 million new cases diagnosed annually, dementia
Amarasate, An Extract of Bitter Hop Flowers Shown Effective For Weight Loss: The Science And Mode Of Action
With the massive interest in the use of glucagon-like peptide-1 (GLP-1) receptor agonists for the management of both Type 2 diabetes and obesity/overweight, it is
The Bone-Loss Problem in the GLP-1 Era
In the GLP-1 era, practitioners are helping patients lose weight faster and in larger amounts than before. That makes skeletal protection increasingly important. This article examines five signals that change during weight loss—mechanical loading, estrogen, calcium balance, gut delivery, and rate—and translates them into practical considerations for screening and intervention.
GLP-1 Weight-Loss Drugs and Optic Nerve Risks: What Clinicians and Patients Should Know
The rapid global adoption of glucagon-like peptide-1 (GLP-1) receptor agonists-such as semaglutide (Ozempic®, Wegovy®) and related agents-has reshaped the pharmaceutical management of diabetes and obesity. As their use
GLP-1 Agonists: Support Protocol
A comprehensive plan for patients taking GLP-1s is crucial—no matter how you feel about it. When GLP-1 agonists first hit the market, frustrated Americans eagerly embraced
Study Finds Link Between Obesity and Key Nutrient Deficiency
Incidence of adult obesity has doubled in the past 25 years, with almost 1 billion people worldwide—about 1 in every 8—classified as obese in 2022. And with
Stopping GLP-1 Receptor Agonists… Why and How to Plan an “Exit Strategy” for Your Patients
In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes in weight
Acknowledging Gender Differences in Obesity Research
With the celebration of International Women’s Day on March 8th, it’s timely to review the differences in women’s health research and how that specifically affects investigations into
Researchers Link Abdominal Fat to Brain Health in Men
According to the World Health Organization, some 55 million people globally suffer from Alzheimer’s disease or dementia. With 10 million new cases diagnosed annually, dementia has become
Amarasate, An Extract of Bitter Hop Flowers Shown Effective For Weight Loss: The Science And Mode Of Action
With the massive interest in the use of glucagon-like peptide-1 (GLP-1) receptor agonists for the management of both Type 2 diabetes and obesity/overweight, it is timely to
Multiple Human Studies Show Significant Weight-Loss Benefits for Amarasate, A Proprietary Extract of Bitter Hops
A trio of studies performed in the past 5 years shows that a proprietary hops extract called Amarasate can help curb hunger and food cravings.
The New Wave of Weight Loss
Blending pharmaceuticals, nutraceuticals and integrative approaches for safe, sustainable weight loss that works. Of all the challenges encountered by practitioners, helping patients achieve and maintain weight loss
New Research Uncovers Additional Reasons to Eat Kimchi
Kimchi, a traditional Korean dish made by salting and fermenting vegetables with various flavorings and seasonings, is well known as a health food. Cabbage and radish are
Intermittent Fasting May Reduce Risk of Type-2 Diabetes
A new study in Nature Medicine shows that a time-restricted, intermittent fasting diet lowered the risk of diabetes more than a reduced-calorie diet.